ID

34475

Descripción

Preoperative Magnetic Resonance (MR) Imaging of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01347320

Link

https://clinicaltrials.gov/show/NCT01347320

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 27/5/19 27/5/19 -
  3. 29/5/19 29/5/19 - Sarah Riepenhausen
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT01347320

Eligibility Prostate Cancer NCT01347320

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
all patients suitable for surgery.
Descripción

ID.1

Tipo de datos

boolean

positive biopsy (gleason grade >3).
Descripción

ID.2

Tipo de datos

boolean

informed consent.
Descripción

ID.3

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who do not sign the consent paper for any reason or do not accept the study premises.
Descripción

ID.4

Tipo de datos

boolean

patents who want to withdraw for any reason during the study.
Descripción

ID.5

Tipo de datos

boolean

patients with contraindications to mri (pacemaker, claustrophobia etc) and/or surgery.
Descripción

ID.6

Tipo de datos

boolean

patients who have undergone a high quality mri examination of the prostate at another radiological center. in this situation the mr examination is evaluated together with the surgeon but the patient is not included in the study. (in case of a low quality examinations, we will disregard the findings, and include the patient).
Descripción

ID.7

Tipo de datos

boolean

if the surgeon finds it unacceptable to perform ralp without mri, because of various reasons (eg. patient demand, too high risk etc) the patient will not be included in the study.
Descripción

ID.8

Tipo de datos

boolean

if preoperative mri reveals extensive tumor invasion into adjacent organ (t4) or skeletal metastases (m1), as these cancer stadiums do not benefit from ralp.
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Prostate Cancer NCT01347320

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
all patients suitable for surgery.
boolean
ID.2
Item
positive biopsy (gleason grade >3).
boolean
ID.3
Item
informed consent.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
patients who do not sign the consent paper for any reason or do not accept the study premises.
boolean
ID.5
Item
patents who want to withdraw for any reason during the study.
boolean
ID.6
Item
patients with contraindications to mri (pacemaker, claustrophobia etc) and/or surgery.
boolean
ID.7
Item
patients who have undergone a high quality mri examination of the prostate at another radiological center. in this situation the mr examination is evaluated together with the surgeon but the patient is not included in the study. (in case of a low quality examinations, we will disregard the findings, and include the patient).
boolean
ID.8
Item
if the surgeon finds it unacceptable to perform ralp without mri, because of various reasons (eg. patient demand, too high risk etc) the patient will not be included in the study.
boolean
ID.9
Item
if preoperative mri reveals extensive tumor invasion into adjacent organ (t4) or skeletal metastases (m1), as these cancer stadiums do not benefit from ralp.
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial